How Do I Leave You Well? | HDL Link to Parkinson’s Disease | Doubling SemaglutideJuly 26, 2021 | Trending in Healthcare Family Medicine/General Practice A Resignation Letter to My Patients: How Do I Leave You Well? In this KevinMD.com podcast/article, the nurse practitioner sums up their current feelings in the last words of the piece: “If I leave now, I still deal with this for months, plus all of my patient’s grief and feelings of betrayal. If I stay, maybe it will get better. It could hardly get worse. But in the end, I don’t want to lose myself either, and at some point, there has to be a line that is too far. It is just hard to know what that is anymore.” Read full article Cardiology HDL Cholesterol Linked to Parkinson’s Disease A population-based longitudinal study in Korea showed relationships between high-density lipoprotein cholesterol (HDL-C) levels and variability with incident Parkinson’s disease (PD). People with a baseline HDL-C under 40 mg/dL were more likely to develop PD than those with HDL-C of 60 mg/dL or more, confirming previous findings but still questioning how variability in HDL-C may be linked to PD. Read full article Endocrinology, Diabetes, Metabolism Doubling Semaglutide Dose Helps Get HbA1c Under Control According to the SUSTAIN FORTE study presented online in The Lancet Diabetes & Endocrinology, doubling the dose of semaglutide (Ozempic) might be a helpful option for people not achieving glycemic goals. Still, some researchers aren’t convinced this is a sound strategy – “statistically significant but barely clinically relevant” — suggesting opting for another agent when faced with a patient struggling to control HbA1c. Read full article